Home ›
Organizations ›
AMYLOIDOSIS RESEARCH CONSORTIUM INC
AMYLOIDOSIS RESEARCH CONSORTIUM INC
MA · Medical Research · EIN 472589708
7
Executives Disclosed
$3.4M
Annual Revenue
$4.7M
Total Assets
AMYLOIDOSIS RESEARCH CONSORTIUM INC has 7 executives with disclosed compensation. The highest-paid executive, Isabelle Lousada (PRESIDENT/CEO & SECRETARY), received peak total compensation of $178,365. The sector average for Medical Research executives is $311K.
Top Executive Compensation Over Time
Executive Compensation
| Name | Title | Peak Comp. | Latest Comp. | Years | vs. Household |
|---|---|---|---|---|---|
| Isabelle Lousada | PRESIDENT/CEO & SECRETARY | $178K | $178K | 2016–2023 | 2.4x |
| Vanessa Boulanger | DIR OF PATIENT ENGAGEMENT | $132K | $0 | 2022–2022 | 1.8x |
| Kristen Hsu | EXECUTIVE DIRECTOR OF CLINICAL RESEARCH | $125K | $0 | 2018–2022 | 1.7x |
| Robyn Himick | ASSOC. DIR. OF CLINICAL RESEARCH | $111K | $0 | 2018–2021 | 1.5x |
| Eric Low | FORMER DIRECTOR | $75K | $0 | 2017–2017 | 1x |
| Mary Ellen Thomas | EXEC. OPERATIONS OFFICER | $62K | $0 | 2016–2016 | 0.8x |
| Liv Woods | SECRETARY/DIR OF OPERATIONS | $61K | $0 | 2019–2019 | 0.8x |
Annual Summary
| Year | Executives | Avg. Comp. | Highest Comp. | Total Payroll |
|---|---|---|---|---|
| 2016 | 2 | $0 | $0 | $0 |
| 2017 | 2 | $0 | $0 | $0 |
| 2018 | 3 | $0 | $0 | $0 |
| 2019 | 4 | $0 | $0 | $0 |
| 2020 | 2 | $0 | $0 | $0 |
| 2021 | 3 | $0 | $0 | $0 |
| 2022 | 3 | $174K | $174K | $174K |
| 2023 | 1 | $178K | $178K | $178K |
Email Alerts
Get notified about AMYLOIDOSIS RESEARCH CONSORTIUM INC
Get an email when a new IRS Form 990 filing is posted that includes this organization. We send a confirmation link first - we don't add you to any other list.